Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
KB.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GK.11NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GK.11NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GK.11NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
CJ.1.3.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
CJ.1.3.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CJ.1.3.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XANNUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XANNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XANNChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BN.1.4.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BN.1.4.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BN.1.4.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
DV.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
DV.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DV.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.5.2.11NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.5.2.11NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.2.11NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.53NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.2.53NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.53NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.4.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.4.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.4.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
EU.1.1.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
EU.1.1.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EU.1.1.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
CM.2.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
CM.2.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CM.2.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.43NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.43NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.43NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
HU.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
HU.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HU.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JB.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JB.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JB.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
A.2.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.256NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.256NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.256NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.26NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.26NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.26NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.177.77NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.177.77NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.177.77NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used